Parkinson's Disease Clinical Trial
Official title:
Can Dual Task Walking Improve in Parkinson's Disease After External Focus of Attention Exercise? A Single Blind Randomized Controlled Trial
The purpose of this study is to evaluate the underlying mechanism and influence of externally vs. internally focused exercise on rehabilitation in Parkinson's disease. The upcoming exercise intervention methodology will aim to meet the requirements of a 1A silver ranking level, single blind, randomized control trial according to the criterion of the Cochrane Musculoskeletal Review Group
Parkinson's disease is a slow progressing neurodegenerative movement disorder with both motor
and non-motor symptoms. The gold standard medical pharmacotherapy (levodopa) lends relief
from symptoms. However, some of the non-motor symptoms are not responsive to this therapy or
eventually become non-responsive, such as impaired proprioception (sensory feedback from the
limbs providing awareness of one's body in physical space). Although it is unclear as to why
levodopa is unable to relieve proprioception impairments, a key underlying mechanism that may
be responsible is an impaired sensorimotor integration (the combination of sensory and motor
information in the brain utilized to guide movements). This is not the result of corrupted
input information from proprioceptors into the brain (such as muscle spindles and golgi
tendon organs), but rather the downstream integration of this information in the brain. With
faulty signalling through the area of the brain damaged in Parkinson's disease (the basal
ganglia), deficient sensorimotor integration impairs patients' ability to rely on sensory
feedback during movement. This subsequently impairs ability to automatize learned movements
in Parkinson's disease and causes previously automatic movements (such as walking) to require
conscious control (lose automaticity). This is problematic in instances where attention is
diverted from a movement that is no longer automatically controlled, such as engaging in a
conversation while walking. Without attention on the movement, motor control breaks down,
leading to heightened chance of falls and injury. However, Wulf and Colleagues (2009)
demonstrated that when individuals with Parkinson's disease focused externally, and greater
reliance on sensorimotor integration was fostered, balance control was improved compared to
when these individuals focused attention internally. This suggests that individuals with
Parkinson's disease may retain ability to rely on sensorimotor integration. Therefore, by
fostering neuroplasticity through the basal ganglia with the utilization of exercise, and
improving ability to rely on sensorimotor integration in individuals with Parkinson's disease
(by using dual task training), automaticity of movements may be improved, subsequently
decreasing the risk of falling and injury. Furthermore, by improving sensorimotor
integration, symptom severity might improve and disease progression may slow.
In addition to providing improvements to symptoms of Parkinson's disease, this will provide a
greater understanding into the pathophysiological mechanisms underlying improvements
associated with exercise rehabilitations employed for Parkinson's disease. To date,
goal-directed exercises have yet to investigate the rudimentary aspects of the exercise,
since no studies have directly compared identical exercise regimens while participants focus
"internally" on the movements of their limbs compared to focusing "externally" on the
movement of an object that is being manipulated. For this reason, this study will investigate
large magnitude gait and balance training in two groups, one focusing internally on limb
movements throughout the exercise program, and the other focusing externally on the movement
of coloured labels attached to their limbs. The gait, balance, stretching and coordination
exercises that will be provided in the proposed intervention to the two exercise groups will
follow the exact Parkinson's disease Sensory Attention Focused Exercise (PD-SAFEx™) protocol
designed by Sage and Almeida (2009). PD-SAFEx™ is a group setting intervention, which will be
led by the primary investigator who is trained in conducting the exercise protocol. The first
half of the exercise class will include walking exercises that include large magnitude and
coordinated movements. All walking will be performed slowly. Walking exercises will be
followed by balance, stretching, and coordination exercises while sitting in, or standing
near, standard office chairs, utilizing latex Thera-bands®. To ensure that balance and
coordination are constantly challenged throughout the intervention, the exercise program
progresses each week, increasing in difficulty.
Sixty-five participants diagnosed with idiopathic Parkinson's disease will be recruited. This
present intervention study will span over a 20- week period. Pre-assessments to measure
baseline symptoms and functionality will be conducted over the initial 2-week period prior to
the start of the intervention. After pre-assessments have been conducted, participants will
be randomized to one of three groups:
Group 1: Internal Focus of attention Exercise (Original PD-SAFEx™) While performing the
exercises in PD-SAFEx™, participants will be instructed to focus their attention on sensory
feedback. This will include focusing participants' attention on the stretch in their limbs
while walking, on the straightness of their backs while sitting, on limb and body orientation
in space while coordinating their movements, and on chest movements during breathing
exercises. Throughout each exercise session, the instructor and volunteers will constantly
provide attention-directing instructions.
Group 2: External Focus of attention Exercise (Modified PD-SAFEx™) While performing the
exercises from the PD-SAFEx™ program, participants will be instructed to focus their
attention towards the movement of coloured labels attached to their hands, elbows, knees and
feet.
Group 3: Control Group This group will be asked to refrain from changing activities of their
daily lives throughout the 20-week duration of the experiment (from pre-assessment to
washout).
The exercise program will follow the pre-assessment baseline measures, and will last 12
weeks. Each exercise session will last 60 minutes, and will be provided three times per week.
Post-assessment of all outcome measures tested prior to the intervention will be assessed in
a 2-week period immediately after the cessation of the exercise program. The washout period
will last 6 weeks; thereafter assessments will be completed again. Since the present research
study aims to understand the mechanism underlying these rehabilitations, as well as ensure
ecological validity, symptom severity (UPDRS-III) will be assessed in all individuals in both
the "ON" and "OFF" state of dopaminergic medication. Since the individuals are in the "ON"
state during all daily activities, exercise classes will be performed in the "ON"
dopaminergic medication state. If there are individuals who are naïve to dopaminergic
medication (De novo), they will only be assessed once (in the "OFF" dopaminergic state). All
individuals included in the rehabilitation program will be required to complete a Physical
Activity Readiness Medical Examination (ParMed X), signed by a physician prior to joining the
rehabilitation program.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02915848 -
Long-term Stability of LFP Recorded From the STN and the Effects of DBS
|
||
Recruiting |
NCT03648905 -
Clinical Laboratory Evaluation of Chronic Autonomic Failure
|
||
Terminated |
NCT02688465 -
Effect of an Apomorphine Pump on the Quality of Sleep in Parkinson's Disease Patients (POMPRENELLE).
|
Phase 4 | |
Completed |
NCT05040048 -
Taxonomy of Neurodegenerative Diseases : Observational Study in Alzheimer's Disease and Parkinson's Disease
|
||
Active, not recruiting |
NCT04006210 -
Efficacy, Safety and Tolerability Study of ND0612 vs. Oral Immediate Release Levodopa/Carbidopa (IR-LD/CD) in Subjects With Parkinson's Disease Experiencing Motor Fluctuations
|
Phase 3 | |
Completed |
NCT02562768 -
A Study of LY3154207 in Healthy Participants and Participants With Parkinson's Disease
|
Phase 1 | |
Completed |
NCT00105521 -
Sarizotan in Participants With Parkinson's Disease Suffering From Treatment Associated Dyskinesia
|
Phase 3 | |
Completed |
NCT00105508 -
Sarizotan HC1 in Patients With Parkinson's Disease Suffering From Treatment-associated Dyskinesia
|
Phase 3 | |
Recruiting |
NCT06002581 -
Repetitive Transcranial Magnetic Stimulation(rTMS) Regulating Slow-wave to Delay the Progression of Parkinson's Disease
|
N/A | |
Completed |
NCT02236260 -
Evaluation of the Benefit Provided by Acupuncture During a Surgery of Deep Brain Stimulation
|
N/A | |
Completed |
NCT00529724 -
Body Weight Gain, Parkinson, Subthalamic Stimulation
|
Phase 2 | |
Active, not recruiting |
NCT05699460 -
Pre-Gene Therapy Study in Parkinson's Disease and Multiple System Atrophy
|
||
Completed |
NCT03703570 -
A Study of KW-6356 in Patients With Parkinson's Disease on Treatment With Levodopa-containing Preparations
|
Phase 2 | |
Completed |
NCT03462680 -
GPR109A and Parkinson's Disease: Role of Niacin in Outcome Measures
|
N/A | |
Completed |
NCT02837172 -
Diagnosis of PD and PD Progression Using DWI
|
||
Not yet recruiting |
NCT04046276 -
Intensity of Aerobic Training and Neuroprotection in Parkinson's Disease
|
N/A | |
Recruiting |
NCT02952391 -
Assessing Cholinergic Innervation in Parkinson's Disease Using the PET Imaging Marker [18F]Fluoroethoxybenzovesamicol
|
N/A | |
Active, not recruiting |
NCT02937324 -
The CloudUPDRS Smartphone Software in Parkinson's Study.
|
N/A | |
Terminated |
NCT02894567 -
Evaluation of Directional Recording and Stimulation Using spiderSTN
|
N/A | |
Completed |
NCT02874274 -
Vaccination Uptake (VAX) in PD
|
N/A |